Spanish researchers develop five-strain Ebola vaccine
Spanish researchers are working on a vaccine against all five strains of the killer Ebola virus in what would be a world first, Madrid's October 12 Hospital said Wednesday.
Jul 11, 2018
0
313
Spanish researchers are working on a vaccine against all five strains of the killer Ebola virus in what would be a world first, Madrid's October 12 Hospital said Wednesday.
Jul 11, 2018
0
313
Protein fragments, called amyloid fibrils, in human semen significantly increase Ebola virus infection and protect the virus against harsh environmental conditions such as heat and dehydration. Researchers from the Perelman ...
Jun 25, 2018
0
30
The phylogenetic tree of the 2013-2016 Ebola epidemic doesn't just reveal how the Ebola virus was able to evolve—it also reveals which events and preventive measures accelerated or slowed down its spread. These findings ...
Jun 12, 2018
0
31
At the start of the epidemic in West Africa, the Ebola virus did not change as rapidly as thought at the time. ETH researchers explain why scientists misjudged it at the time.
Apr 5, 2018
0
52
Boston University researchers, led by John Connor, associate professor of microbiology at the Boston University School of Medicine and researcher at Boston University's National Emerging Infectious Diseases Laboratories (NEIDL), ...
Mar 28, 2018
0
28
University of Alberta researchers have found the Ebola polymerase (enzyme), which may lead to more effective research and better treatments for the often fatal infection, and other related viral diseases.
Mar 7, 2018
0
42
With a mortality rate of up to 88 percent, Marburg virus can rip through a community in days. In 2005, an outbreak of Marburg virus struck a pediatric ward in the country of Angola. With no treatment available, doctors struggled ...
Jan 10, 2018
0
41
In a comprehensive and complex molecular study of blood samples from Ebola patients in Sierra Leone, published today (Nov. 16, 2017) in Cell Host and Microbe, a scientific team led by the University of Wisconsin-Madison has ...
Nov 16, 2017
0
395
Results from a large randomized, placebo-controlled clinical trial in Liberia show that two candidate Ebola vaccines pose no major safety concerns and can elicit immune responses by one month after initial vaccination that ...
Oct 11, 2017
0
26
Ebola virus RNA can persist in the semen of survivors more than two years after the onset of infection researchers at the University of North Carolina at Chapel Hill have found. The research team, which included investigators ...
Aug 2, 2017
0
19